L’endométriose est-elle une lésion pré-cancéreuse ? Perspectives et implications cliniques
review
OA: closed
CC0
⤵ 9 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This paper explores the hypothesis that endometriosis may act as a pre-cancerous lesion and discusses the clinical implications of this perspective.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (71)
- A histologic study of ovarian endometriosis with emphasis on hyperplastic and atypical changes. via openalex
- Assessing Ovarian Cancer Risk When Considering Elective Oophorectomy at the Time of Hysterectomy via openalex
- Association between endometriosis and cancer: A comprehensive review and a critical analysis of clinical and epidemiological evidence via openalex
- Economic burden of endometriosis via openalex
- ENDOMETRIAL CARCINOMA OF THE OVARY, ARISING IN ENDOMETRIAL TISSUE IN THAT ORGAN via openalex
- EPIDEMIOLOGY OF ENDOMETRIOSIS via openalex
- Hepatocyte nuclear factor (HNF)-1β and its physiological importance in endometriosis via openalex
- <i>ARID1A</i> Mutations in Endometriosis-Associated Ovarian Carcinomas via openalex
- Incessant ovulation and ovarian cancer â a hypothesis re-visited via openalex
- <i>PIK3CA</i> mutation is an early event in the development of endometriosis‐associated ovarian clear cell adenocarcinoma via openalex
- <i><scp>ARID</scp>1A</i> expression in ovarian clear cell carcinoma with an adenofibromatous component via openalex
- Loss of ARID1A/BAF250a expression in ovarian endometriosis and clear cell carcinoma. via openalex
- Loss of ARID1A Expression Is an Early Molecular Event in Tumor Progression From Ovarian Endometriotic Cyst to Clear Cell and Endometrioid Carcinoma via openalex
- Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. via openalex
- Malignant changes in endometriosis. via openalex
- Malignant degeneration of perineal endometriosis in episiotomy scar, case report and review of the literature via openalex
- Met Is the Most Frequently Amplified Gene in Endometriosis-Associated Ovarian Clear Cell Adenocarcinoma and Correlates with Worsened Prognosis via openalex
- Multifocal endometriotic lesions associated with cancer are clonal and carry a high mutation burden via openalex
- New insights in the pathophysiology of ovarian cancer and implications for screening and prevention via openalex
- Ovarian cancer: new developments in clear cell carcinoma and hopes for targeted therapy via openalex
- Ovarian cancers arising from endometriosis: A microenvironmental biomarker study including ER, HNF1ß, p53, PTEN, BAF250a, and COX-2 via openalex
- Ovarian endometrioma—Risks factors of ovarian cancer development via openalex
- Potential scenarios leading to ovarian cancer arising from endometriosis via openalex
- The <i>ARID1A</i> pathway in ovarian clear cell and endometrioid carcinoma, contiguous endometriosis, and benign endometriosis via openalex
- The 'incessant menstruation' hypothesis: a mechanistic ovarian cancer model with implications for prevention via openalex
- Understanding the role of epigenomic, genomic and genetic alterations in the development of endometriosis (Review) via openalex
- W2063560014 via openalex
- W2063609078 via openalex
- W2071457506 via openalex
- W2072451938 via openalex
- W1975141727 via openalex
- W1970131592 via openalex
- W2083955107 via openalex
- W2086830762 via openalex
- W2088626912 via openalex
- W2090287261 via openalex
- W2092324058 via openalex
- W2095085832 via openalex
- W1967187359 via openalex
- W1754419963 via openalex
- W2102273403 via openalex
- W2103540939 via openalex
- W2103894337 via openalex
- W2125681453 via openalex
- W2128458428 via openalex
- W2140963269 via openalex
- W2144603423 via openalex
- W2145080208 via openalex
- W2147960762 via openalex
- W2155216639 via openalex
- W2162321914 via openalex
- W2164340315 via openalex
- W2165404212 via openalex
- W2168083201 via openalex
- W2403342305 via openalex
- W1521030336 via openalex
- W2473756112 via openalex
- W6601256010 via openalex
- W6605136881 via openalex
- W6638686170 via openalex
- W6678253711 via openalex
- W2024474882 via openalex
- W1214944030 via openalex
- W2027114592 via openalex
- W2013678879 via openalex
- W2031238872 via openalex
- W2032032056 via openalex
- W2036170298 via openalex
- W2048902285 via openalex
- W2053309322 via openalex
- W2054097842 via openalex
Cited by (9)
- Evaluation of expression of biomarkers of PLAGL1 (ZAC1), microRNA, and their non-coding RNAs in patients with endometriosis 2023
- Evaluation of the relationship between miR-1271 and GRB2 gene in endometriosis 2022
- Epithelial Ovarian Cancer 2021
- Endometriosis and Menopause: Realities and Management 2020
- Incidence of endometriosis and atypical endometriosis in epithelial ovarian tumors 2019
- Endometriosis and the menopause: why the question merits our full attention 2019
- Endometriosis and endometriosis-associated cancers: new insights into the molecular mechanisms of ovarian cancer development 2018
- Response to Dr Nohuz's letter: Could prophylactic salpingectomy replace tubal ligation? 2017
- 10.1016/s0246-1064(17)65070-9 2000
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:21:13.485820+00:00
License: CC0
· commercial use OK